featured
Adjuvant Trastuzumab Emtansine vs Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial
J. Clin. Oncol 2021 Jun 02;[EPub Ahead of Print], SM Tolaney, N Tayob, C Dang, DA Yardley, SJ Isakoff, V Valero, M Faggen, T Mulvey, R Bose, J Hu, D Weckstein, AC Wolff, K Reeder-Hayes, HS Rugo, B Ramaswamy, D Zuckerman, L Hart, VK Gadi, M Constantine, K Cheng, F Briccetti, B Schneider, AM Garrett, K Marcom, K Albain, P DeFusco, N Tung, B Ardman, R Nanda, RC Jankowitz, M Rimawi, V Abramson, PR Pohlmann, C Van Poznak, A Forero-Torres, M Liu, K Ruddy, Y Zheng, SM Rosenberg, RD Gelber, L Trippa, W Barry, M DeMeo, H Burstein, A Partridge, EP Winer, I KropFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.